MolMed news - the latest biotech news from Labiotech.eu

Home MolMed

Latest Posts

Cell and Gene Therapies Europe

Interview 18 Apr 2018

What Lies Ahead for European Cell and Gene Therapies?

Cell and gene therapies have recently made big advances in providing effective treatments for a variety of conditions, from cancers to rare diseases. Nonetheless, there are still significant challenges ahead…

April 18, 2018 - 5 minutesmins - By Alexander Burik

biotech dinosaurs cover2 1

In Depth 23 Jan 2018

Walking with the Dinosaurs of European Biotech: Which of Them is Roaring the Loudest?

Although biotech may seem like an industry that has only just gotten started, it was already up and running before the turn of the century. We took a look back…

January 23, 2018 - 10 minutesmins - By Alex Dale

MolMed ITW Cover2 1

Interview 4 Dec 2017

Meet the CEO Leading Italy’s Charge to Become a Major Biotech Player

Riccardo Palmisano is CEO of MolMed, the most important Italian biotech, which focuses on gene and cell therapies. We chatted about the company, which hopes to give the cancer therapies…

December 4, 2017 - 7 minutesmins - By Alex Dale

chromosome koya979 FI

News and Trends 19 Sep 2016

Italian Gene Therapy Biotech aims high by Collaborating with US Giant Amgen

Genenta Science and Amgen have teamed up to develop gene therapies for cancer. The Italian biotech from Milan raised €10M in series A funding last year and is already getting ready…

September 19, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

ADVERTISEMENT

molmed graft host disease zalmoxis leukemia

News and Trends 28 Jun 2016

Will the Leading Italian Biotech soon have its First Cell therapy on the Market?

MolMed has received conditional market approval for Zalmoxis, an ex vivo genetically engineered cell therapy that stops immune rejection of transplanted hematopoietic stem cells. This is a big step forward in a key…

June 28, 2016 - 2 minutesmins - By Denise Neves Gameiro

molmed biotech of the week header

News and Trends 1 Apr 2016

Biotech of the Week: MolMed, Immuno-oncology made in ‘Milano’

From one fashion capital to the other, this week we leave Paris and head down to Milan. Home to some worldwide high-fashion brands, Da Vinci's Last Supper mural and main city…

April 1, 2016 - 1 minutemin - By Joachim Eeckhout

Beyond Biotech - the podcast from Labiotech

View More

Newsletter Signup - Sidebar

"*" indicates required fields